Omicron sibling BA.2 remains variant of concern: World Health Organisation

The Omicron variant of concern is currently the dominant variant circulating globally, accounting for nearly all sequences reported to GISAID (an open access database), said the WHO in a statement

WHO
File Photo
IANS Geneva
2 min read Last Updated : Feb 23 2022 | 3:07 PM IST

Amid concerns of increasing presence of the BA.2 subtype of Omicron variant in some European and Asian countries, the World Health Organization (WHO) on Wednesday reinforced that the BA.2 sublineage should continue to be considered a variant of concern.

The WHO's Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE), which met on Tuesday said that it should remain classified as Omicron.

The group also emphasised that BA.2 should continue to be monitored as a distinct sublineage of Omicron by public health authorities.

"The Omicron variant of concern is currently the dominant variant circulating globally, accounting for nearly all sequences reported to GISAID (an open access database)," the WHO said in a statement.

Omicron is made up of several sublineages, each of them being monitored by WHO and partners. Of them, the most common ones are BA.1, BA.1.1 (or Nextstrain clade 21K) and BA.2 (or Nextstrain clade 21L).

At a global level, the proportion of reported sequences designated BA.2 has been increasing relative to BA.1 in recent weeks, however the global circulation ofA all variants is reportedly declining.

The experts explained that BA.2 differs from BA.1 in its genetic sequence, and that it has a growth advantage over this sublineage.

Although studies are ongoing to understand why, initial data suggest BA.2 appears inherently more transmissible than BA.1, currently the most common Omicron sublineage reported.

However, this difference in transmissibility appears to be much smaller than that between BA.1 and the Delta variant, the experts said.

Meanwhile, although BA.2 sequences are increasing in proportion relative to other Omicron sublineages, there is still a reported decline in overall cases globally.

Furthermore, while cases of reinfection with BA.2 following infection with BA.1 have been documented, preliminary data from studies show that infection with BA.1 provides strong protection against reinfection with BA.2.

WHO will continue to closely monitor the BA.2 lineage as part of Omicron.

The UN agency urged countries to remain vigilant, to monitor and report sequences, and to conduct independent and comparative analyses of the different Omicron sublineages.

--IANS

rvt/ksk/

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusOmicronDelta variant of coronavirusWorld Health OrganisationCoronavirus VaccineCoronavirus TestsWHO

First Published: Feb 23 2022 | 3:07 PM IST

Next Story